Tiova Inhaler
Indicated for chronic obstructive pulmonary disease, formulated to alleviate breathing difficulties and support respiratory function in patients managing long-term lung health.
- Category
- Respiratory Health
- Active ingredient
- Tiotropium
- Supply
- Pharmacy
- Route
- Inhalation use
- Form
- Inhalation powder
- Strengths
- 9mcg
Tiova Inhaler details
- Alternative names
- Spiriva; Tiova
- Therapeutic class
- Anticholinergic Bronchodilator
- Pharmacological class
- Long-acting Muscarinic Antagonist (LAMA)
- Contraindications
- hypersensitivity to tiotropium
- Precautions and warnings
- avoid contact with eyes; monitor for paradoxical bronchospasm
- Minor side effects
- dry mouth
- Moderate side effects
- constipation; blurred vision
- Dosage forms
- Inhalation powder
- Administration route
- Inhalation use
- Supply category
- Pharmacist only, dispensed without a prescription
- Manufacturer
- Boehringer Ingelheim
- Onset Time
- 30–60 minutes
- Duration
- 24 hours
- Storage instructions
- Store in a cool, dry place away from direct sunlight.
- Drug interactions
- ipratropium
- Age restrictions
- Adults only.
Serious side effects
glaucoma, requires immediate medical attention; urinary retention, requires immediate medical attention
Patient summary
Indicated for chronic obstructive pulmonary disease, formulated to alleviate breathing difficulties and support respiratory function in patients managing long-term lung health.
Mechanism of action
Tiova works by blocking muscarinic receptors in the smooth muscle of the airways. By inhibiting these receptors, it relaxes the bronchial muscles, which helps to keep the airways open for an extended period, making it easier to breathe for individuals managing chronic obstructive pulmonary disease.
Pregnancy and breastfeeding
Pregnancy: limited data available, consult your doctor. Breastfeeding: safety not established, weigh benefits against potential risks.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Tiova Inhaler
Tiova Inhaler contains tiotropium, an active ingredient used to manage the symptoms of Chronic Obstructive Pulmonary Disease. Manufactured by Boehringer Ingelheim, this medication is also sold under the brand name Spiriva. Supplied as an inhaler with a strength of 9mcg, it provides a solution for those managing daily respiratory maintenance.
Buying Tiova Inhaler online
Tiova Inhaler is one of the most frequently ordered respiratory devices across the region, currently registered in 13 markets including Japan, the UAE and Singapore. Availability also extends to Hong Kong, Thailand and Malaysia, offering a practical solution for expats and residents living far from a well stocked medical facility. As generic tiotropium is often more affordable than the original brand, this product provides an accessible option for patients seeking consistent support.